Characterization of a Large Group of Individuals with Huntington Disease and Their Relatives Enrolled in the COHORT Study
Open Access
- 16 February 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (2) , e29522
- https://doi.org/10.1371/journal.pone.0029522
Abstract
Careful characterization of the phenotype and genotype of Huntington disease (HD) can foster better understanding of the condition. We conducted a cohort study in the United States, Canada, and Australia of members of families affected by HD. We collected demographic and clinical data, conducted the Unified Huntington's Disease Rating Scale and Mini-Mental State Examination, and determined Huntingtin trinucleotide CAG repeat length. We report primarily on cross-sectional baseline data from this recently completed prospective, longitudinal, observational study. As of December 31, 2009, 2,318 individuals enrolled; of these, 1,985 (85.6%) were classified into six analysis groups. Three groups had expanded CAG alleles (36 repeats or more): individuals with clinically diagnosed HD [n = 930], and clinically unaffected first-degree relatives who had previously pursued [n = 248] or not pursued [n = 112] predictive DNA testing. Three groups lacked expanded alleles: first-degree relatives who had previously pursued [n = 41] or not pursued [n = 224] genetic testing, and spouses and caregivers [n = 430]. Baseline mean performance differed across groups in all motor, behavioral, cognitive, and functional measures (p<0.001). Clinically unaffected individuals with expanded alleles weighed less (76.0 vs. 79.6 kg; p = 0.01) and had lower cognitive scores (28.5 vs. 29.1 on the Mini Mental State Examination; p = 0.008) than individuals without expanded alleles. The frequency of “high normal” repeat lengths (27 to 35) was 2.5% and repeat lengths associated with reduced penetrance (36 to 39) was 2.7%. Baseline analysis of COHORT study participants revealed differences that emerge prior to clinical diagnosis. Longitudinal investigation of this cohort will further characterize the natural history of HD and genetic and biological modifiers. Clinicaltrials.gov NCT00313495Keywords
This publication has 30 references indexed in Scilit:
- Mild cognitive impairment in prediagnosed Huntington diseaseNeurology, 2010
- Prevalence of Incompletely Penetrant Huntington's Disease Alleles Among Individuals With Major Depressive DisorderAmerican Journal of Psychiatry, 2010
- CAG‐repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approachesAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2010
- Dietary intake in adults at risk for Huntington diseaseNeurology, 2009
- Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27–35 CAG)American Journal of Medical Genetics Part A, 2009
- Detection of Huntington's disease decades before diagnosis: the Predict-HD studyJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Factors associated with HD CAG repeat instability in Huntington diseaseJournal of Medical Genetics, 2007
- Reduced penetrance alleles for Huntington's disease: a multi-centre direct observational studyJournal of Medical Genetics, 2006
- Critical Periods of Suicide Risk in Huntington’s DiseaseAmerican Journal of Psychiatry, 2005
- Suicide risk in Huntington's disease.Journal of Medical Genetics, 1993